Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy

M. J. Garabedian, W. F. Hansen, E. A. Gianferrari, K. Y. Lain, R. Y. Fragneto, C. L. Campbell, D. C. Booth

Research output: Contribution to journalArticlepeer-review

12 Scopus citations


Idiopathic pulmonary arterial hypertension is a rare condition associated with significant maternal mortality. We report the management of a 37-year-old multigravida with severe disease using epoprostenol, a multidisciplinary approach, and a planned delivery. Although the patient survived the pregnancy, her pulmonary function significantly worsened. Epoprostenol, a pulmonary vasodilator, should be considered when indicated during pregnancy. Neither fetal nor neonatal harm was identified.

Original languageEnglish
Pages (from-to)628-631
Number of pages4
JournalJournal of Perinatology
Issue number9
StatePublished - Sep 2010

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Obstetrics and Gynecology


Dive into the research topics of 'Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy'. Together they form a unique fingerprint.

Cite this